7-溴-2-氯喹唑啉-4-胺 | 1107695-08-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 中文名称: 7-溴-2-氯喹唑啉-4-胺
• 英文名称: 7-bromo-2-chloroquinazolin-4-amine
• CAS: 1107695-08-8
• 化学式: C₈H₅BrClN₃
• 分子量: 258.505
• InChiKey: RCPHEXPZUNHZNL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  51.8
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  tert-butyl ((2S,3R)-3-(tert-butoxy)-1-oxo-1-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)hydrazinyl)butan-2-yl)carbamate 、 7-溴-2-氯喹唑啉-4-胺 在 bis-triphenylphosphine-palladium(II) chloride 、 sodium carbonate 作用下， 以 水 为溶剂， 以22%的产率得到tert-butyl ((2R,3R)-1-((3-(4-amino-2-chloroquinazolin-7-yl)phenyl)sulfonamido)-3-(tert-butoxy)butan-2-yl)carbamate
  参考文献：
  名称：

  Identification of Bacteria-Selective Threonyl-tRNA Synthetase Substrate Inhibitors by Structure-Based Design

  摘要：

  A series of potent and bacteria-selective threonyl-tRNA synthetase (ThrRS) inhibitors have been identified using structure-based drug design. These compounds occupied the substrate binding site of ThrRS and showed excellent binding affinities for all of the bacterial orthologues tested. Some of the compounds displayed greatly improved bacterial selectivity. Key residues responsible for potency and bacteria/human ThrRS selectivity have been identified. Antimicrobial activity has been achieved against wild-type Haemophilus influenzae and efflux-deficient mutants of Escherichia coli and Burkholderia thailandensis.

  DOI：

  10.1021/jm301756m

文献信息

• [EN] INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF<br/>[FR] INHIBITEURS DE RÉPLICATION DU VIRUS DE LA GRIPPE, PROCÉDÉS D'APPLICATION ET UTILISATIONS ASSOCIÉES
  申请人：SUNSHINE LAKE PHARMA CO LTD

  公开号：WO2018033082A1

  公开（公告）日：2018-02-22

  A class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the treatment of influenza.

  一类化合物作为流感病毒复制抑制剂，其制备方法，含有这些化合物的药物组合物，以及这些化合物和药物组合物在治疗流感中的用途。
• [EN] BETA-ADRENERGIC RECEPTOR ALLOSTERIC MODULATORS<br/>[FR] MODULATEURS ALLOSTÉRIQUES DE RÉCEPTEURS BÊTA-ADRÉNERGIQUES
  申请人：UNIV CALIFORNIA

  公开号：WO2019204768A1

  公开（公告）日：2019-10-24

  Provided herein are modulators of beta-adrenergic receptors.

  这里提供了β肾上腺素受体的调节剂。
• BETA-ADRENERGIC RECEPTOR ALLOSTERIC MODULATORS
  申请人：THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

  公开号：US20210353626A1

  公开（公告）日：2021-11-18

  Provided herein are modulators of beta-adrenergic receptors.
• Identification of Bacteria-Selective Threonyl-tRNA Synthetase Substrate Inhibitors by Structure-Based Design
  作者：Min Teng、Mark T. Hilgers、Mark L. Cunningham、Allen Borchardt、Jeffrey B. Locke、Sunny Abraham、Gregory Haley、Bryan P. Kwan、Courtney Hall、Grayson W. Hough、Karen J. Shaw、John Finn

  DOI：10.1021/jm301756m

  日期：2013.2.28

  A series of potent and bacteria-selective threonyl-tRNA synthetase (ThrRS) inhibitors have been identified using structure-based drug design. These compounds occupied the substrate binding site of ThrRS and showed excellent binding affinities for all of the bacterial orthologues tested. Some of the compounds displayed greatly improved bacterial selectivity. Key residues responsible for potency and bacteria/human ThrRS selectivity have been identified. Antimicrobial activity has been achieved against wild-type Haemophilus influenzae and efflux-deficient mutants of Escherichia coli and Burkholderia thailandensis.